When the Canada-EU trade deal was under negotiation, studies forecast billion-dollar price increases for Canada's health care system when brand-name drug patents are extended. At this point however, the government won't project what the actual cost might be.
from CBC | Express Feed News http://ift.tt/2gJercb
Aucun commentaire:
Enregistrer un commentaire